---
title: "Faeth Therapeutics files initial beneficial ownership statement for Khosla Ventures VI, L.P"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294108113.md"
description: "Faeth Therapeutics filed a Form 3 disclosing that Khosla Ventures VI, L.P. is a 10% beneficial owner, holding 2,632,232 shares indirectly as of June 15, 2026. Holdings are split between Khosla Ventures VI, L.P. (1,643,349 shares) and Khosla Ventures Seed D, L.P. (988,883 shares). The filing was published via EDGAR on July 28, 2026."
datetime: "2026-07-28T20:15:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294108113.md)
  - [en](https://longbridge.com/en/news/294108113.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294108113.md)
---

# Faeth Therapeutics files initial beneficial ownership statement for Khosla Ventures VI, L.P

-   Faeth Therapeutics Form 3 filing disclosed Khosla Ventures VI as a 10% owner, reporting 2,632,232 shares of common stock held indirectly. \* Holdings split between 1,643,349 shares held via Khosla Ventures VI, L.P. and 988,883 shares held via Khosla Ventures Seed D, L.P. \* The ownership statement was triggered on June 15, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-321026), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)

## Related News & Research

- [Faeth Therapeutics CFO Brian C. Stephenson files initial beneficial ownership statement](https://longbridge.com/en/news/290611234.md)
- [Faeth Therapeutics CFO Brian C. Stephenson acquires USD 319,293 of common shares](https://longbridge.com/en/news/291473235.md)
- [Inflection Point Acquisition VI delays Q2 10-Q filing, cites need to finalize financial statements](https://longbridge.com/en/news/296143056.md)
- [M3-Brigade Acquisition VI FY26 Q2 net income rises to $3.02 million](https://longbridge.com/en/news/295970868.md)
- [Figma director Daniel H. Rimer reports disposal of 12,475 common shares for $316,935.25](https://longbridge.com/en/news/295704379.md)